Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA: Two more eyedrops brands recalled due to risks

U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury

The Independent UK

California will cut ties with Walgreens over the company's plan to drop abortion pills

California Gov. Gavin Newsom said that the state would halt business with Walgreens after the pharmacy giant agreed to stop distributing mifepristone in some red states amid legal pressure.

WEKU

Studies Link Marijuana Legalization to All Sorts of Positive Public Health Outcomes

Plus: San Francisco claims to have "significantly disrupted" sex trafficking, a nationwide injunction on abortion pills, and more...

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Stocks to Buy in Any Market Climate

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

StockNews.com

Editorial: Abortion opponents are trying to revoke FDA approval of a drug. That’s scary

In the post-Roe world, one of the prime targets of antiabortion activists is medication abortion, a two-drug regimen in which a pregnant person takes mifepristone followed by misoprostol.

Los Angeles Times

What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications

“Weight loss may turn back your biological age, but it tends to turn your facial clock forward,” one dermatologist says

The Independent UK

Gavin Newsom says California ‘won’t be doing business’ with Walgreens for refusing to sell abortion pills

Walgreens announced last week it will not distribute abortion medication, which is legal, in 20 states

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

1 Medical Stock You Shouldn't Touch With a 10-Foot Pole

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a concern. Moreover, its closest competitor is also close to getting approval. Given its poor financials, stretched valuation, and weak profitability,…

StockNews.com

Are 'Clean Beauty' Products Worth It? Dermatologists Break Down the Wellness Trend

Skincare and cosmetics companies have started touting the importance of "clean beauty," but what does that really mean?

Inverse

Commentary: Want to make drugs, including insulin, affordable? End patent abuse

Drugmaker Eli Lilly on Wednesday said it will drop prices on some versions of insulin, and cap monthly out-of-pocket costs at $35 per product for insured individuals not covered by Medicare’s prescription drug program, which also maintains a $35 cap. The welcome move comes as lawmakers in both major parties…

Tribune News Service

This dental device was sold to fix patients’ jaws. Lawsuits claim it wrecked their teeth

Boja Kragulj, an accomplished clarinetist who once performed with orchestras in New York, Philadelphia and Jacksonville, Florida, has already lost four teeth. And she expects to lose at least a dozen more.

Tribune News Service

What is "healthy?" FDA, makers disagree

Last September, the FDA proposed an updated definition of the food label to incorporate new research on nutrition

Salon

Maryland prepares for federal ruling that could force abortion pill off the market

BALTIMORE — A decision is due any day from a federal court in Texas that could have sweeping repercussions on abortion access across the country — including in states, like Maryland, where the procedure is protected.

Tribune News Service

Walgreens won't sell abortion pills in red states that threatened legal action

The 20 states where Walgreens won't sell mifepristone include some where abortion remains legal. It's not clear whether other retail pharmacies will follow suit.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

The faux outrage over Sue Gray’s move to Labour is a ruse to protect Boris Johnson – don’t fall for it

The matter needs careful handling, but the agenda of those making illogical claims is pretty clear, says Dave Penman, general secretary of the FDA union

The Guardian - US

Walgreens limits abortion pills sales after pressure from conservative states

Republican attorneys general threatened the company with legal consequences for sending pills by mail

The Independent UK

The implications of Walgreens' decision on abortion pills

Walgreens says it will not start selling an abortion pill in 20 states that had warned of legal consequences if it did that

Chicago Sun-Times

Oat and soy can be called milk, FDA proposes

Dairy producers for years have called for the FDA to crack down on plant-based drinks and other products that they say masquerade as animal-based foods and cloud the real meaning of “milk.”

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Guardian - US

Billboards advise on how to get abortion pills in US states where procedure is banned

Mobile billboards on how to get access to pills by mail are being driven through college campuses in 14 states

Fortune

Why this company has spent nine years trying to sell birth control pills without a prescription

HRA Pharma hasn't given up on the long-shot goal.

WEKU

FDA has new leverage over companies looking for a quicker drug approval

The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.

Fortune

No, Elon Musk can’t put chips into people’s brains: Regulators rejected Neuralink’s device due to safety risks, report says

Neuralink’s human brain chip trials have been put on hold after the FDA rejected the startup’s application owing to safety issues, Reuters reported Thursday.

Fortune

An FDA panel has recommended a 2-dose RSV vaccine for older Americans. Here’s when they might be able to get it

The jabs could be ready as soon as this summer, one expert tells Fortune.

Tribune News Service

States seek crackdown on toxic ingredients in cosmetics to close gaps in federal oversight

Washington has joined more than a dozen other states in seeking to crack down on toxic substances in cosmetics after a state-funded study there found lead, arsenic and formaldehyde in makeup, lotion and hair-straightening products made by CoverGirl and other brands.

1 … 149 150 151 152

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.